May 7-11, 2024 | Baltimore
Meet OmniaBio's team of experts in May at ASGCT 2024. Complete the meeting form to:
-
Discuss your program needs and explore how our complete continuum of expertise, capabilities and capacity can help you meet your goals at any stage, from early-stage development through to commercial manufacturing;
-
Learn how you can streamline your path to market with our cutting-edge technology platforms; and,
-
Learn about our newest purpose-built, late phase/commercial facility opening this summer, designed with the flexibility and operational excellence needed to evolve with industry needs.
Our team looks forward to connecting with you and advancing impactful innovations together to help patients in need.
About OmniaBio
As a dedicated cell and gene therapy CDMO, OmniaBio's vision is to manufacture a disease-free future. Headquartered in Ontario, Canada, our core values of collaborative partnership converge with deep industry experience and innovation using the latest technologies to drive the future of cell and gene therapy manufacturing.
